These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9555555)

  • 1. The effect of re-dosing of vasodilators on the intracavernosal pressure and on the penile rigidity.
    de Meyer JM; Thibo P
    Eur Urol; 1998; 33(3):293-6; discussion 296-7. PubMed ID: 9555555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the synergistic effects of tamsulosin versus phentolamine on penile erection: in vitro and in vivo studies.
    Kim SC; Seo KK; Lee SK; Song ES; Lee MY
    Urol Res; 1999 Dec; 27(6):437-44. PubMed ID: 10651132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of satisfactory rigidity after intracavernosal injection with prostaglandin E1 in men with erectile failure.
    Purvis K; Brekke I; Christiansen E
    Int J Impot Res; 1996 Mar; 8(1):9-16. PubMed ID: 8735188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prostaglandin E1 in erectile dysfunction].
    Porst H
    Urologe A; 1989 Mar; 28(2):94-8. PubMed ID: 2655258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of intraurethral liposomal and intracavernosal prostaglandin-E1 in the management of erectile dysfunction.
    Engelhardt PF; Plas E; Hübner WA; Pflüger H
    Br J Urol; 1998 Mar; 81(3):441-4. PubMed ID: 9523667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and duplex US assessment of effects of sildenafil on cavernosal arteries of the penis: comparison with intracavernosal injection of vasoactive agents--initial experience.
    Copel L; Katz R; Blachar A; Sosna J; Sheiman RG
    Radiology; 2005 Dec; 237(3):986-91. PubMed ID: 16237136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcitonin-gene-related peptide: a possible role in human penile erection and its therapeutic application in impotent patients.
    Stief CG; Wetterauer U; Schaebsdau FH; Jonas U
    J Urol; 1991 Oct; 146(4):1010-4. PubMed ID: 1895414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective randomized study to optimize the dosage of trimix ingredients and compare its efficacy and safety with prostaglandin E1.
    Seyam R; Mohamed K; Akhras AA; Rashwan H
    Int J Impot Res; 2005; 17(4):346-53. PubMed ID: 15772683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of a second injection on the pharmaco-induced erection test.
    Pagani E; Puech-Leão P; Glina S; Reis JM
    Int J Impot Res; 1997 Sep; 9(3):167-8. PubMed ID: 9315495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of intracavernosal sodium nitroprusside in impotence.
    Tarhan F; Kuyumcuoğlu U; Kolsuz A; Ozgül A; Cangüven O
    Urol Int; 1996; 56(4):211-4. PubMed ID: 8776816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracavernosal injection of prostaglandin E1 as an alternative for papaverine in penile angiography.
    Wilms G; Peene P; Steeno O; Baert AL
    Urol Radiol; 1992; 14(1):59-61. PubMed ID: 1615576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandin E1 with phentolamine for the treatment of erectile dysfunction.
    Meinhardt W; de la Fuente RB; Lycklama à Nijeholt AA; Vermeij P; Zwartendijk J
    Int J Impot Res; 1996 Mar; 8(1):5-7. PubMed ID: 8735187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why a combined intracavernosal injection with trimix and oral sildenafil is reliable therapy in the ultrasonographic evaluation of erectile dysfunction.
    Park JK; Park JS; Jeon SB; Cui WS; Kim SZ; Kang KK; Lee SW
    BJU Int; 2008 Sep; 102(8):993-7. PubMed ID: 18476965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracavernous pharmacotherapy for impotence: selection of appropriate agent and dose.
    von Heyden B; Donatucci CF; Kaula N; Lue TF
    J Urol; 1993 May; 149(5 Pt 2):1288-90. PubMed ID: 8479018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy using oral alpha-blockers and intracavernosal injection in men with erectile dysfunction.
    Kaplan SA; Reis RB; Kohn IJ; Shabsigh R; Te AE
    Urology; 1998 Nov; 52(5):739-43. PubMed ID: 9801091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of a mixture of papaverine, phentolamine and prostaglandin E1 with other intracavernous injections.
    Meinhardt W; Lycklama à Nijeholt AA; Kropman RF; Vermeij P; Zwartendijk J
    Eur Urol; 1994; 26(4):319-21. PubMed ID: 7713130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Intracavernosal Injection of Prostaglandin E1 on Duration and Rigidity of Erection in Patients With Vasculogenic Erectile Dysfunction: Is It Dose Dependent?
    Bassiem MA; Ismail IY; Salem TA; El-Sakka AI
    Urology; 2021 Feb; 148():173-178. PubMed ID: 33017615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracavernous injection of prostaglandin E1 in combination with papaverine: enhanced effectiveness in comparison with papaverine plus phentolamine and prostaglandin E1 alone.
    Floth A; Schramek P
    J Urol; 1991 Jan; 145(1):56-9. PubMed ID: 1984099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracavernosal therapy for erectile failure--impact of treatment and reasons for drop-out and dissatisfaction.
    Purvis K; Egdetveit I; Christiansen E
    Int J Impot Res; 1999 Oct; 11(5):287-99. PubMed ID: 10553808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo assessment of trabecular smooth muscle tone, its application in pharmaco-cavernosometry and analysis of intracavernous pressure determinants.
    Hatzichristou DG; Saenz de Tejada I; Kupferman S; Namburi S; Pescatori ES; Udelson D; Goldstein I
    J Urol; 1995 Apr; 153(4):1126-35. PubMed ID: 7869480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.